SEC Form 4 · accession 0001104659-18-041867
STEMLINE THERAPEUTICS INC · STML
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ron Bentsur
Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 22, 2018 · 9:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001264587
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 21, 2018 | A | 13,158 | $0.00 | A | 40,443 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted shares will vest according to the following schedule: 4,386 shares on 6/21/2019, 4,386 shares on 6/21/2020 and 4,386 shares on 6/21/2021.
- F2Of the 40,443 shares, 23,157 shares are restricted stock.